Scientists move closer to developing ‘game-changing’ test to diagnose Parkinson’s Date 10 March 2021 Research shows it’s possible to identify Parkinson’s based on compounds found on the surface of skin. The findings offer hope that the condition could be diagnosed through a simple swab test.
We're investing £1.2m into drug that could slow Parkinson's Date 9 March 2021 We’re investing up to £1.2m into pioneering research in partnership with the University of Sheffield, which aims to develop a drug to protect dopamine-producing brain cells.
Our chair Gary Shaughnessy looks ahead to 2021 Date 24 February 2021 In 2020, coronavirus (COVID-19) brought normal life to a standstill. But the Parkinson’s community showed its resilience as people found innovative ways to support each other.
Caption Christine Proctor - participant in the GDNF trial Why we’re committing £800,000 to plan a new GDNF trial Date 23 February 2021 The earlier groundbreaking clinical trial proved inconclusive. So we’re launching a new company tasked with planning a possible new trial.
Parkinson’s ambassador David Jensen joins Jazz FM Date 18 February 2021 The broadcasting legend will front a new 6-part jazz series, which will also highlight the work of Parkinson’s UK.
Further clues about alpha-synuclein Date 11 February 2021 New research has advanced our understanding of a protein called alpha-synuclein, which is believed to play a central role in damaging brain cells in Parkinson’s.
Shan Nicholas joins the team as Interim Chief Executive Date 20 January 2021 As Steve Ford prepares to step down, Shān brings extensive leadership experience from across the charity sector to Parkinson’s UK.
Vision tests predict cognitive decline linked to Parkinson's Date 19 January 2021 Scientists in the UK have uncovered evidence that simple vision tests can predict who will develop Parkinson's dementia. And the evidence shows that a loss of wiring in the brain may be the cause.
New guidance for lab-based researchers on patient and public involvement Date 8 January 2021 We’ve partnered with Alzheimer’s Society and University College London Hospitals (UCLH) Biomedical Research Centre. Together, we’ve developed a new resource to help lab-based researchers with patient and public involvement (PPI).
What we achieved in 2020, together Date 15 December 2020 Parkinson's didn't stop for coronavirus, and neither did we. Here are the three things we’re most proud of this year, and how you can get involved in 2021.
